VNUS Medical Technologies, founded in 1995, markets the VNUS Closure System of products for patients who suffer from symptoms associated with venous reflux. The Closure system provides an alternative to vein stripping surgery or laser vein ablation. Over 500,000 patients worldwide have received the Closure procedure, which is commonly performed in either a doctor’s office or as an out-patient procedure. The VNUS Closure System is currently available for sale in over 40 countries including the United States, Canada, and numerous countries in Europe, South America, and Asia.
In June 2009, Covidien plc announced that one of its subsidiaries has completed the acquisition of VNUS Medical Technologies, Inc.
CSRHub includes data on Diversity & Labor Rights, Employees, Environment, long term investment, Human Rights & Supply Chain, and causes of global warming.